Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02062255 · ClinicalTrials.gov registry record · Early Phase 1
Impact of COX2 on Sera Biomarkers From Obese Subjects
A Early Phase 1 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 126
- Enrollment target
NCT02062255: Completed Early Phase 1 study, sponsored by The University of Texas Health Science Center at San Antonio.
NCT02062255 is a Early Phase 1 study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 126 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (138% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02062255, a Early Phase 1 study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 126 participants
- Enrollment target
Study Summary
Obesity promotes worse outcome for post-menopausal breast cancer patients.
Primary Outcome
Blood levels of Prostaglandin E2, aromatase, pro-inflammatory cytokines, steroids, and lipids will be measured pre and post treatment.
Interventions
- DRUG Aspirin
- DIETARY_SUPPLEMENT Omega 3 FFA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-04 |
| Phase | Early Phase 1 |
What the finished NCT02062255 record still lists
NCT02062255 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (138% higher).
The record links to 0 conditions, and to 2 interventions - of which Aspirin is the first listed.
NCT02062255 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02062255 about?
NCT02062255 is a clinical study titled "Impact of COX2 on Sera Biomarkers From Obese Subjects". Obesity promotes worse outcome for post-menopausal breast cancer patients.
What is the current status of trial NCT02062255?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 126 participants. The study started on 2013-10. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02062255?
The interventions under investigation include: Aspirin (DRUG), Omega 3 FFA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02062255?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02062255's enrollment target sits among peer trials
126 140th of 2000 higher than 1,859 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia